European Journal of Dermatology

, Volume 24, Issue 2, pp 274–275 | Cite as

Idiopathic hypereosinophilic syndrome with multiple organ infarction: improvement of the skin condition masking the course of disease

  • Hannes Trattner
  • Friedrich Breier
  • Andreas Steiner
  • Marlies Wruhs
  • Robert Feldmann


Allergy Clin Immunol Telmisartan Tamsulosin Bullous Pemphigoid Hypereosinophilic Syndrome 


  1. 1.
    Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975; 54: 1–27.CrossRefGoogle Scholar
  2. 2.
    Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012; 130: 607–612.PubMedCrossRefGoogle Scholar
  3. 3.
    Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009; 124: 1319–1325.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008; 358: 1215–1228.PubMedCrossRefGoogle Scholar
  5. 5.
    Simon HU, Klion A. Therapeutic Approaches to Patients with Hypereosinophilic Syndromes. Semin Hematol 2012; 49: 160–170.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Park SM, Park JW, Kim SM, et al. A case of hypereosinophilic syndrome presenting with multiorgan infarctions associated with disseminated intravascular coagulation. Allergy Asthma Immunol Res 2012; 4: 161–164.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006; 117: 1292–1302.PubMedCrossRefGoogle Scholar
  8. 8.
    Helbig G, Wisniewska-Piaty K, Francuz T, Dziaczkowska-Suszek J, Kyrcz-Krzemien S. Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients. Leuk Lymphoma 2013; 54: 807–811.PubMedCrossRefGoogle Scholar
  9. 9.
    Podjasek JC, Butterfield JH. Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature. Leuk Res 2013; 37: 392–395.PubMedCrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2014

Authors and Affiliations

  • Hannes Trattner
    • 1
  • Friedrich Breier
    • 2
  • Andreas Steiner
    • 2
  • Marlies Wruhs
    • 2
  • Robert Feldmann
    • 2
  1. 1.Department of Gastroenterology and HepatologyMedical University of ViennaViennaAustria
  2. 2.Department of DermatologyHietzing Municipal HospitalViennaAustria

Personalised recommendations